Technical Analysis for MTZPY - Mitsubishi Tanabe Pharma Corporation

Grade Last Price % Change Price Change
grade F 10.78 -2.00% -0.2200
MTZPY closed down 2.0 percent on Thursday, August 22, 2019, on 83 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MTZPY trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -2.00%
Up 3 Days in a Row Strength -2.00%
Up 4 Days in a Row Strength -2.00%
Up 5 Days in a Row Strength -2.00%
Pocket Pivot Bullish Swing Setup -1.82%
Up 3 Days in a Row Strength -1.82%
Up 4 Days in a Row Strength -1.82%
Oversold Stochastic Weakness -1.82%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.73%
Spinning Top Other -1.73%

Older signals for MTZPY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Mitsubishi Tanabe Pharma Corporation manufactures and sells pharmaceuticals in Japan, Europe, North America, other Asian countries, and internationally. The company offers drugs for autoimmune, diabetes, kidney, central nervous system, and other disease treatment; and vaccines, as well as sells generic drugs and over-the-counter (OTC) products. It offers Remicade for treatment of rheumatoid arthritis (RA), Crohn's, Bechet's, psoriasis, ankylosing spondylitis, and ulcerative colitis diseases; Simponi for the treatment of RA; Kremezin for the treatment of chronic renal failure; and Tenelia for type II diabetes mellitus. The company also provides Ceredist for the treatment of spinocerebellar degeneration; Depas, an anti-anxiety agent; Lexapro, an anti-depressant agent; Imusera for multiple sclerosis; Radicut, a cerebral neuroprotectant; Talion for the treatment of allergic disorders; Maintate for the treatment of hypertension, angina pectoris, ventricular extrasystole, chronic heart failure, and atrial fibrillation; Urso that improves hepatic, biliary, and digestive functions; and Anplag, an anti-platelet agent. In addition, it offers TETRABIK, a vaccine for diphtheria, pertussis, tetanus, and poliomyelitis; Varicella vaccine for the prevention of chicken pox; Influenza vaccine; Mearubik, a vaccine for measles and rubella; and JEBIK V for the prevention of Japanese encephalitis. Further, the company provides OTC products, including agents for the treatment of skin conditions; tonic and nutritional supplements; herbal and digestive medicines; and oral agents for allergic rhinitis and recurrent vaginal candidiasis. Additionally, it provides information about pharmaceuticals; and invests in bio-ventures. The company has collaborations with Dyadic International, Inc.; Hitachi Ltd.; and HitGen Ltd. The company was founded in 1678 and is headquartered in Osaka, Japan. The company is a subsidiary of Mitsubishi Chemical Holdings Corporation.
Medicine RTT Medical Specialties Pharmaceuticals Drugs Diabetes Pharmaceutical Industry In China Medication Disease Hypertension Multiple Sclerosis Psoriasis Rheumatoid Arthritis Influenza Vaccines Allergic Rhinitis Atrial Fibrillation Treatment Of Hypertension Angina Pectoris Chronic Heart Failure Janssen Biotech Measles Rhinitis Spondylitis Chronic Renal Failure Crohn's Japanese Encephalitis Remicade Rubella Tnf Inhibitors Varicella Allergic Disorders Chicken Pox Diphtheria Golimumab Ii Diabetes Mellitus Pertussis Poliomyelitis Prevention Of Chicken Pox Recurrent Vaginal Candidiasis Schering Plough Spinocerebellar Degeneration Tetanus Treatment Of Allergic Disorders Treatment Of Chronic Renal Failure Ulcerative Colitis Diseases Ventricular Extrasystole
Is MTZPY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 17.53
52 Week Low 10.6
Average Volume 53,668
200-Day Moving Average 13.1677
50-Day Moving Average 11.1481
20-Day Moving Average 11.075
10-Day Moving Average 10.9155
Average True Range 0.2633
ADX 19.49
+DI 23.867
-DI 20.9362
Chandelier Exit (Long, 3 ATRs ) 11.1461
Chandelier Exit (Short, 3 ATRs ) 11.4299
Upper Bollinger Band 11.5102
Lower Bollinger Band 10.6398
Percent B (%b) 0.16
BandWidth 7.859142
MACD Line -0.0883
MACD Signal Line -0.0786
MACD Histogram -0.0097
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.0800
Resistance 3 (R3) 11.1033 11.0267 11.0300
Resistance 2 (R2) 11.0267 10.9503 11.0150 11.0133
Resistance 1 (R1) 10.9033 10.9031 10.9650 10.8800 10.9967
Pivot Point 10.8267 10.8267 10.8575 10.8150 10.8267
Support 1 (S1) 10.7033 10.7503 10.7650 10.6800 10.5633
Support 2 (S2) 10.6267 10.7031 10.6150 10.5467
Support 3 (S3) 10.5033 10.6267 10.5300
Support 4 (S4) 10.4800